Recherche
-
The Burden of Potentially Inappropriate Medications in Chronic Polypharmacy
(Journal of Clinical Medicine. vol. 9, n° 11, pp. 3728, 2020-11-20)Article de revueLibre accès -
Risk of suicide attempt and suicide associated with benzodiazepine: A nationwide case crossover study.
(Acta Psychiatrica Scandinavica. vol. 148, n° 3, pp. 233-241, 2023-09-01)Article de revueLibre accès -
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
(The Lancet Regional Health - Europe. vol. 17, 2022-06)Article de revueLibre accès -
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis.
(Frontiers in Pharmacology. vol. 14, pp. 1129244, 2023-05-15)Article de revueLibre accès -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre accès -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre accès -
Artificial intelligence for unstructured healthcare data: application to coding of patient reporting of adverse drug reactions
(Clinical Pharmacology and Therapeutics, 2021-04-18)Article de revueLibre accès -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
(Drug Safety. vol. 46, n° 9, pp. 857-866, 2023-09-01)Article de revueLibre accès -
Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
(Frontiers in Pharmacology. vol. 10, pp. 265, 2019-03)Article de revueLibre accès -
Propensity Score-Based Approaches in High Dimension for Pharmacovigilance Signal Detection: an Empirical Comparison on the French Spontaneous Reporting Database
(Frontiers in Pharmacology. vol. 9, pp. 1010, 2018-09)Article de revueLibre accès